Related Experiment Videos
Does an educational leaflet improve self-reported adherence to therapy in osteoporosis? The OPTIMA study
Summary
An educational leaflet did not improve osteoporosis medication adherence in post-menopausal women. However, health-related quality of life (HRQOL) improved over 12 months of raloxifene treatment.
Area of Science:
- Osteoporosis management
- Pharmacological treatment adherence
- Health-related quality of life
Background:
- Poor adherence to osteoporosis treatment is a significant clinical challenge.
- Effective strategies are needed to improve medication adherence and patient outcomes.
Purpose of the Study:
- To evaluate the impact of an educational leaflet on medication adherence in post-menopausal women with osteoporosis.
- To assess the association between treatment adherence and health-related quality of life (HRQOL).
Main Methods:
- A 12-month, multi-center, observational study involving 745 post-menopausal women treated with raloxifene.
- Two groups: Group A received an educational leaflet; Group B followed standard care.
- Adherence assessed using the Morisky test; HRQOL measured with the EuroQoL questionnaire.
Main Results:
- No significant difference in raloxifene adherence between groups at 12 months (47.4% vs 52.5%).
- Health-related quality of life (HRQOL) improved significantly in both groups over 12 months (mean EQ VAS increment of 9.2).
- Weak correlations were observed between adherence and HRQOL.
Conclusions:
- An educational leaflet did not enhance medication adherence for osteoporosis treatment.
- HRQOL improved during raloxifene therapy, irrespective of the educational intervention.
- No consistent correlation was found between adherence and HRQOL in this cohort.
